NGR was found to bind the aminopeptidase N (APN/CD13) receptor isoform that is upregulated in tumor vasculature, and shows a three-fold higher specificity than the RGD peptide toward tumor area [19, 20]. The gene discussed is RTN4R; the disease is neoplasm.